Our results of stereotactic radiotherapy in advanced stage lung cancer patients

A. F. Oruç, N. Özseker, S. Karabulut Gül, M. Koçak, H. Özyurt, D. Gedik, E. Algül, O. Malas Oruç, A. Mayadagli (Istanbul, Izmir, Turkey)

Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Session: Therapy of thoracic tumours: clinical trials and case series
Session type: Thematic Poster Session
Number: 2720
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. F. Oruç, N. Özseker, S. Karabulut Gül, M. Koçak, H. Özyurt, D. Gedik, E. Algül, O. Malas Oruç, A. Mayadagli (Istanbul, Izmir, Turkey). Our results of stereotactic radiotherapy in advanced stage lung cancer patients. Eur Respir J 2014; 44: Suppl. 58, 2720

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Stereotactic ablative radiotherapy (SABR) in non-surgical non small cell lung cancer: Effects on respiratory function
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013


Comparing performance and cost of EBUS-TBNA versus other methods for diagnosis and staging of non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


Is there a change in pulmonary function in patients with COPD and primary lung cancer treated with radiofrequency ablation (RFA)?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014



Brain metastatic recurrence following radically treated lung cancer; a retrospective analysis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014


Does consolidation chemotherapy improves survival for locally advanced non-small-cell lung cancer patients receiving concurrent chemoradiotherapy?
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Role of mean sUV and metabolic tumor volume by PET/CT for determination of mean survival time in patients with non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014


EBUS-TBNA for nodal restaging and relapse in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014

CyberKnife radiosurgery for early stage nonsmall cell lung cancer
Source: Annual Congress 2013 –Advances in the therapy of lung cancer
Year: 2013

Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015

Adrenalectomy for isolated lesions in operable patients with non-small-cell lung cancer
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016

Outcomes of radical treatment of early stage non-small cell lung cancer
Source: International Congress 2015 – Lung cancer therapy: clinical trials
Year: 2015


Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


Functional impairment of NK cells in non-small-cell lung cancer
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014

Diaphragm motion and lung function prediction in patients operated for lung cancer – A pilot study on 27 patients
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013

Lung cancer patients
Source: Eur Respir Monogr 2021; 90: 165-180
Year: 2021


Pemetrexed in maintenance therapy of 164 patients with advanced non-small-cell lung cancer (NSCLC)
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Impact of second-line treatment on overall survival of advanced lung adenocarcinoma patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

The risk of recurrence after intraoperative needle biopsy(INB) for preoperative undiagnosed early stage lung cancers
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

What predicts radiation pneumonitis best? Pulmonary injury after curatively intended radiotherapy of early-stage lung cancer
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016